UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
November 19, 2021
Accession Number:
0001104659-21-140539
Submission Type:
POS AM
CIK:
0001616212
Company Name:
Trillium Therapeutics Inc.
File Number:
333-224983